Vialology is an independent publication about the science of peptides — the short chains of amino acids that have become one of the most talked-about, and most misunderstood, subjects in modern health.
Peptides sit at a strange intersection of cutting-edge research, wellness hype, regulatory grey areas, and genuine scientific promise. Headlines outrun the evidence; marketing outruns the headlines. Our job is to slow that down — to explain what a peptide actually is, what the research actually shows, and where the honest open questions remain.
What we cover
We report across six areas: the underlying science of how peptides work, new research and studies, neutral profiles of individual compounds, their role in health and longevity, the industry and regulation shaping the field, and plain-language guides and explainers for newcomers.
How we approach the evidence
We write in the language of research, not recommendation. When we describe a study, we tell you what kind it was and when it was done. We distinguish animal models from human trials, and preliminary findings from established science. When a compound is experimental or not approved by the FDA, we say so.
What we are not
Vialology does not sell peptides or tell anyone how to use any substance. Some articles include clearly disclosed affiliate or partner links to third-party suppliers of research-grade peptides; these links help fund our work and never influence what we cover or the conclusions we reach. Nothing we publish is medical advice. Peptides can carry real risks, and decisions about your health belong between you and a licensed healthcare professional.
Educational use only. Vialology publishes journalistic and educational content about peptide science. Nothing here is medical advice, diagnosis, or treatment, and nothing should be taken as an endorsement to use any substance. Many peptides discussed are experimental and are not approved by the FDA for human use. Always consult a licensed healthcare professional before making any health decision.